Stay updated on Secukinumab in Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Secukinumab in Psoriatic Arthritis: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.2. The prior government-funding notice (Revision: v3.4.1) has been removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:44:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice added regarding government funding lapse and NIH Clinical Center operating status; page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T05:28:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Minor UI/text updates on the study page, including adding a Show glossary option, capitalizing 'Last Update Submitted that Met QC Criteria' instead of 'Last Update Submitted that met QC Criteria', introducing 'No FEAR Act Data', and adding 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:09:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A minor versioning update was made: Revision: v3.3.4 added and Revision: v3.3.3 removed; this appears in site metadata and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:28:37.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The Study Locations section was updated to include a broad set of site regions across the US (Arizona, California, Colorado, Florida, Illinois, Louisiana, Michigan, Missouri, Nebraska, New York, Oklahoma, Pennsylvania, South Carolina, Texas, Vermont, Washington), Australia (New South Wales, Queensland, Tasmania, Victoria), Canada (British Columbia, Manitoba, Quebec), the Czech Republic, and London; the HHS Vulnerability Disclosure link and several prior Location headings were removed.
    Difference
    2%
    Check dated 2025-12-23T12:31:25.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.1 to v3.3.2. This UI/backend update does not alter study content.
    Difference
    0.0%
    Check dated 2025-12-01T16:41:46.000Z thumbnail image

Stay in the know with updates to Secukinumab in Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.